Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

SEC digs into Pfizer's overseas profits, tax reductions

This article was originally published in Scrip

Executive Summary

Pfizer had some "splainin' to do" when the Securities & Exchange Commission (SEC) said the pharma giant's reported domestic operations pre-tax losses of $2.2 billion in the US in 2011, with international operations producing pre-tax earnings of $15 billion, didn't quite jibe with what the firm reported for domestic and international revenues, which that year were $26.9 billion and $40.5 billion, respectively.



Related Companies